Literature DB >> 1011990

Fibrin-stabilizing factor (factor XIII).

C G Curtis, L Lorand.   

Abstract

Mesh:

Substances:

Year:  1976        PMID: 1011990     DOI: 10.1016/s0076-6879(76)45018-8

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  17 in total

1.  The conformational changes of alpha 2-macroglobulin induced by methylamine or trypsin. Characterization by extrinsic and intrinsic spectroscopic probes.

Authors:  L J Larsson; P Lindahl; C Hallén-Sandgren; I Björk
Journal:  Biochem J       Date:  1987-04-01       Impact factor: 3.857

Review 2.  Transglutaminases.

Authors:  L Lorand; S M Conrad
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

3.  Isolation of a polymorphic genomic clone from chromosome 7. Physical and genetic linkage studies to markers around the cystic fibrosis locus.

Authors:  K A Davies; L Lorand; M Waterfield; B Wainwright; M Farrall; R Williamson
Journal:  Hum Genet       Date:  1987-10       Impact factor: 4.132

4.  Characterization of cDNA coding for human factor XIIIa.

Authors:  U Grundmann; E Amann; G Zettlmeissl; H A Küpper
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

5.  Contribution of fibrin stabilization to clot strength. Supplementation of factor XIII-deficient plasma with the purified zymogen.

Authors:  L Shen; L Lorand
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

6.  Difference between type I autoimmune inhibitors of fibrin stabilization in two patients with severe hemorrhagic disorder.

Authors:  S Lopaciuk; K Bykowska; J M McDonagh; R P McDonagh; W J Yount; C R Fuller; L Cooperstein; A Gray; L Lorand
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

7.  Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.

Authors:  C S Greenberg; C C Miraglia; F R Rickles; M A Shuman
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

8.  Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis.

Authors:  Y Sakata; N Aoki
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

9.  Release of alpha 2-plasmin inhibitor from plasma fibrin clots by activated coagulation factor XIII. Its effect on fibrinolysis.

Authors:  J Mimuro; S Kimura; N Aoki
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

10.  "Fibrinogen Tokyo II". An abnormal fibrinogen with an impaired polymerization site on the aligned DD domain of fibrin molecules.

Authors:  M Matsuda; M Baba; K Morimoto; C Nakamikawa
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.